A Win For Vaxart, Inc.

Mon 14 Sep 20 at 05:36 PM
A Win For Vaxart, Inc.

Vaxart, Inc. (VXRT:NASDAQ) rocketted at $7.78, representing a gain of 46.8%. The stock appeared on our News Catalysts scanner on Mon 14 Sep 20 at 04:39 PM in the 'INVESTOR UPDATE' category. From Fri 28 Aug 20, the stock recorded 33.33% Up Days and 30.00% Green Days

The stock spiked on Wed 02 Sep 20 at $6.94 with a volume of 38M+, and its share price has been moving sideways in recent weeks.

About Vaxart, Inc. (VXRT:NASDAQ)

Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.